VIRIDIAN THERAPEUTICS INC's ticker is VRDN and the CUSIP is 92790C104. A total of 126 filers reported holding VIRIDIAN THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 4.13 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,606,957 | -37.9% | 104,756 | -3.7% | 0.74% | -37.2% |
| Q2 2023 | $2,587,519 | +7.2% | 108,765 | +14.6% | 1.18% | -39.8% |
| Q1 2023 | $2,414,485 | -17.3% | 94,909 | -5.1% | 1.97% | +13.4% |
| Q4 2022 | $2,920,474 | +39.1% | 99,982 | -2.3% | 1.73% | +44.6% |
| Q3 2022 | $2,100,000 | +303.1% | 102,372 | +127.3% | 1.20% | +280.6% |
| Q2 2022 | $521,000 | -42.6% | 45,039 | -8.2% | 0.32% | -45.4% |
| Q1 2022 | $907,000 | – | 49,065 | – | 0.58% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| VR Adviser, LLC | 3,082,622 | $47,287,421 | 4.98% |
| COMMODORE CAPITAL LP | 2,200,000 | $33,748,000 | 3.94% |
| Paradigm Biocapital Advisors LP | 3,681,747 | $56,477,999 | 3.83% |
| Vivo Capital, LLC | 1,678,207 | $25,743,695 | 2.82% |
| Fairmount Funds Management LLC | 1,369,623 | $21,010,017 | 2.53% |
| Octagon Capital Advisors LP | 1,067,143 | $16,369,974 | 2.52% |
| ACUTA CAPITAL PARTNERS, LLC | 224,339 | $3,441,360 | 2.31% |
| Logos Global Management LP | 1,050,000 | $16,107,000 | 2.15% |
| Kopp Family Office, LLC | 214,290 | $3,287 | 2.08% |
| 5AM Venture Management, LLC | 410,000 | $6,289,400 | 1.81% |